Real-world experience with pacritinib for patients with myelofibrosis refractory to ruxolitinib: a report of three cases
Our cases contribute to the growing body of evidence supporting pacritinib's role in the evolving treatment landscape of MF.
Authors
- Mona Al‐Rasheed
- Sonia Otsmane
- Taghreed Al Essa
- Mohammad Zureiqi
Institutions
- Adan Hospital (KW)
- Jahra Hospital (KW)
- Instituto Nacional de las Mujeres (MX)
Publication Details
- Journal
- Hospital Practice
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1080/21548331.2025.2572958
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00